Telesis Bio has named William Kullback as its CFO, effective immediately. As CFO, Kullback will be responsible for the company’s financial planning and analysis, accounting, audit, tax, and treasury functions. With more than twenty-eight years of experience as a CFO, Kullback has held a broad range of financial management and operational roles, primarily in mid-sized to large corporations, including multiple publicly held life-science companies.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TBIO:
- Telesis Bio Appoints William J. Kullback Chief Financial Officer
- Telesis Bio downgraded to Sector Weight from Overweight at KeyBanc
- Telesis Bio reports Q2 EPS (28c), consensus (32c)
- Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
- Telesis Bio files to sell 30.04M shares of common stock for holders
